Insulet Corporation (PODD)
undefined
undefined%
At close: undefined
270.24
0.24%
After-hours Dec 13, 2024, 07:35 PM EST

Company Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.

It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager.

The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.

Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation
Insulet Corporation logo
Country United States
IPO Date May 15, 2007
Industry Medical - Devices
Sector Healthcare
Employees 3,000
CEO Dr. James R. Hollingshead Ph.D.

Contact Details

Address:
100 Nagog Park
Acton, Massachusetts
United States
Website https://www.insulet.com

Stock Details

Ticker Symbol PODD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001145197
CUSIP Number 45784P101
ISIN Number US45784P1012
Employer ID 04-3523891
SIC Code 3841

Key Executives

Name Position
Dr. James R. Hollingshead Ph.D. President, Chief Executive Officer & Director
Ana Maria Chadwick Executive Vice President, Chief Financial Officer & Treasurer
Mark Field Senior Vice President & Chief Technology Officer
Angela Geryak Wiczek Senior Director of Corporate Communications
Eric Benjamin Executive Vice President, Chief Product & Customer Experience Officer
John Wodick Kapples J.D. Senior Vice President & General Counsel
June Lazaroff Senior Director of Investor Relations
Laetitia Cousin Senior Vice President of Regulatory Affairs, Quality Assurance & Compliance
Lauren Budden Group Vice President, Chief Accounting Officer & Controller
Prem Singh Senior Vice President of Global Operations

Latest SEC Filings

Date Type Title
Dec 11, 2024 4 Filing
Dec 04, 2024 8-K Current Report
Nov 13, 2024 4 Filing
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 08, 2024 10-Q Quarterly Report
Nov 07, 2024 8-K Current Report
Oct 07, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 12, 2024 4 Filing
Sep 11, 2024 4 Filing
Sep 10, 2024 4 Filing